{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T06:49:16Z","timestamp":1764053356679,"version":"3.41.2"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.pharep.2013.12.002","type":"journal-article","created":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T05:45:56Z","timestamp":1393911956000},"page":"320-324","source":"Crossref","is-referenced-by-count":12,"title":["The effects of new sigma (\u03c3) receptor ligands, PB190 and PB212, in the models predictive of antidepressant activity"],"prefix":"10.1007","volume":"66","author":[{"given":"Gra\u017cyna","family":"Skuza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Witold","family":"Sadaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Kabzi\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Cassano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Gasparre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Abate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Berardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2013.12.002_bib0005","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1002\/cmdc.201200246","article-title":"2-Aminopyridine derivatives as potential \u03c3(2) receptor antagonists","volume":"7","author":"Abate","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.pharep.2013.12.002_bib0010","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2174\/138161212799436485","article-title":"Classes of sigma2 (\u03c32) receptor ligands: structure affinity relationship (SAfiR) studies and antiproliferative activity","volume":"18","author":"Abate","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharep.2013.12.002_bib0015","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.ejmech.2013.09.018","article-title":"Development of 3,4-dihydroisoquinolin-1(2H)-one derivatives for the positron emission tomography (PET) imaging of \u03c32 receptors","volume":"69","author":"Abate","year":"2013","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharep.2013.12.002_bib0020","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2174\/138161212799436539","article-title":"The therapeutic potential of sigma (\u03c3) receptors for the treatment of central nervous system diseases: evaluation of the evidence","volume":"18","author":"Banister","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharep.2013.12.002_bib0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/1871524910909030205","article-title":"1-Cyclohexylpiperazine and 3,3-dimethylpiperidine derivatives as sigma-1 (sigma1) and sigma-2 (sigma2) receptor ligands: a review","volume":"9","author":"Berardi","year":"2009","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"10.1016\/j.pharep.2013.12.002_bib0030","doi-asserted-by":"crossref","first-page":"8237","DOI":"10.1021\/jm050654o","article-title":"Methyl substitution on the piperidine ring of N-[omega-(6-methoxynaphthalen-1-yl)alkyl] derivatives as a probe for selective binding and activity at the \u03c31 receptor","volume":"48","author":"Berardi","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharep.2013.12.002_bib0035","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/BF00233244","article-title":"Biphasic effects of sigma ligands on the neuronal response to N-methyl-d-aspartate","volume":"351","author":"Bergeron","year":"1995","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pharep.2013.12.002_bib0040","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2174\/157015908787386113","article-title":"Pharmacology of therapeutic potential of sigma 1 receptor ligands","volume":"6","author":"Cobos","year":"2008","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.pharep.2013.12.002_bib0045","doi-asserted-by":"crossref","first-page":"14848","DOI":"10.1016\/S0021-9258(18)63778-0","article-title":"Effector coupling mechanisms of the cloned 5-HT1A receptor","volume":"264","author":"Fargin","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharep.2013.12.002_bib0050","doi-asserted-by":"crossref","first-page":"7612","DOI":"10.1016\/j.bmc.2011.10.023","article-title":"Synthesis and binding assays of novel 3,3-dimethylpiperidine derivatives with various lipophilicities as \u03c31 receptor ligands","volume":"19","author":"Ferorelli","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pharep.2013.12.002_bib0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pharmthera.2010.04.003","article-title":"Sigma receptors: potential targets for a new class of antidepressant drug","volume":"127","author":"Fishback","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharep.2013.12.002_bib0060","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejphar.2012.03.021","article-title":"The sigma-1 receptor antagonist PB212 reduces the Ca2+-release through the inositol (1,4,5)-trisphosphate receptor in SK-N-SH cells","volume":"684","author":"Gasparre","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2013.12.002_bib0065","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0014-2999(80)90083-7","article-title":"\u03b1-Adrenoceptors in rat brain: sodium changes the affinity of agonists for prazosin sites","volume":"61","author":"Glossmann","year":"1980","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2013.12.002_bib0070","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0022-3565(24)39299-7","article-title":"Ca(2+) signaling via sigma(1)-receptors: novel regulatory mechanism affecting intracellular Ca(2+) concentration","volume":"293","author":"Hayashi","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2013.12.002_bib0075","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1124\/jpet.103.051284","article-title":"Sigma-1 receptors (sigma(1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export","volume":"306","author":"Hayashi","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2013.12.002_bib0080","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/sj.bjp.0701336","article-title":"Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7)","volume":"122","author":"Jasper","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharep.2013.12.002_bib0085","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1124\/jpet.106.103697","article-title":"Enhancement of antidepressant-like effects but not brain-derived neurotrophic factor mRNA expression by the novel N-methyl-d-aspartate receptor antagonist neramexane in mice","volume":"318","author":"Kos","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2013.12.002_bib0090","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-3565(25)30536-7","article-title":"The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog","volume":"197","author":"Martin","year":"1976","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2013.12.002_bib0095","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0014-2999(96)00497-9","article-title":"\u03c31 Receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test","volume":"312","author":"Matsuno","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2013.12.002_bib0100","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0006-8993(94)91397-8","article-title":"Behavioral evidence for a modulating role of \u03c3 ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia","volume":"647","author":"Maurice","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.pharep.2013.12.002_bib0105","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.bmc.2013.01.034","article-title":"Investigation of r receptors agonist\/antagonist activity through. N-(6-methoxytetralin-1-yl)- and N-(6-methoxynaphthalen-1-yl)alkylderivatives of polymethylpiperidines","volume":"21","author":"Niso","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pharep.2013.12.002_bib0110","doi-asserted-by":"crossref","first-page":"11166","DOI":"10.1158\/0008-5472.CAN-07-1771","article-title":"Sigma-1 receptors bind cholesterol and remodel lipid rafts in breast cancer cell lines","volume":"67","author":"Palmer","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharep.2013.12.002_bib0115","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1111\/j.0953-816X.2004.03297.x","article-title":"Involvement of the sigma1 receptor in the modulation of dopaminergic transmission by amantadine","volume":"19","author":"Peeters","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharep.2013.12.002_bib0120","unstructured":"Phase I Clinical Trial. Clinical Trials.gov Identifier: NCT00968656. Assessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1 (FISO PET\/CT)."},{"key":"10.1016\/j.pharep.2013.12.002_bib0125","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.pharep.2013.12.002_bib0130","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0028-3908(02)00055-2","article-title":"Synergistic effects of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats","volume":"42","author":"Rog\u00f3\u017c","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharep.2013.12.002_bib0135","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.bbr.2008.11.036","article-title":"Sigma-1 receptor knockout mice display a depressive-like phenotype","volume":"198","author":"Sabino","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharep.2013.12.002_bib0140","doi-asserted-by":"crossref","first-page":"30308","DOI":"10.1074\/jbc.M102297200","article-title":"D2\/D3 dopamine receptor heterodimers exhibit unique functional properties","volume":"276","author":"Scarselli","year":"2001","journal-title":"Biol Chem"},{"key":"10.1016\/j.pharep.2013.12.002_bib0145","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2174\/138161212799436458","article-title":"Pharmacology of sigma (\u03c3) receptor ligands from a behavioral perspective","volume":"18","author":"Skuza","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharep.2013.12.002_bib0150","first-page":"923","article-title":"Potential antidepressant activity of sigma ligands","volume":"55","author":"Skuza","year":"2003","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pharep.2013.12.002_bib0155","first-page":"217","article-title":"The synergistic effect of selective sigma receptor agonists and uncompetitive NMDA receptor antagonists in the forced swim test in rats","volume":"57","author":"Skuza","year":"2006","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.pharep.2013.12.002_bib0160","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S1734-1140(11)70722-8","article-title":"Effects of PB190 and PB212, new \u03c3 receptor ligands, on glucocorticoid receptor-mediated gene transcription in LMCAT cells","volume":"63","author":"Skuza","year":"2011","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2013.12.002_bib0165","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharep.2013.12.002_bib0170","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0091-3057(98)00093-8","article-title":"Beneficial effects of acute and repeated administrations of sigma receptor agonists on behavioral despair in mice exposed to tail suspension","volume":"61","author":"Ukai","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharep.2013.12.002_bib0175","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1254\/jphs.10191FP","article-title":"Pharmacological interaction with the sigma1 (\u03c31)-receptor in the acute behavioral effects of antidepressants","volume":"115","author":"Villard","year":"2011","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.pharep.2013.12.002_bib0180","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S1734-1140(13)71080-6","article-title":"Involvement of NMDA and AMPA receptors in the antidepressant-like activity of antidepressant drugs in the forced swim test","volume":"65","author":"Wolak","year":"2013","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2013.12.002_bib0185","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1021\/jm0614883","article-title":"Fluorine-18-labeled benzamide analogues for imaging the sigma2 receptor status of solid tumors with positron emission tomography","volume":"50","author":"Tu","year":"2007","journal-title":"J Med Chem"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014000486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014000486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:35:20Z","timestamp":1752611720000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2013.12.002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1734114014000486"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2013.12.002","relation":{},"ISSN":["1734-1140"],"issn-type":[{"type":"print","value":"1734-1140"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}